Organisation
- Acronym
- NCBR
- Role
- Partner
- Country
- PL
- Address
- ul. Chmielna 6900-801 Warszawa
- Website
- https://www.gov.pl/web/ncbr
Partner
PL
PL
National Centre for Research and Development
NCBR
Programme phases
4
TRANSCAN-1
2011–2014
View phase
TRANSCAN-2
2015–2021
View phase
TRANSCAN-3
2021–2027
View phase
TRANSCAN-4
2026–2031
View phase
Funding participation
Joint calls funded by this organisation.
Funded projects
Projects linked to this funding organisation.
ABC-Cancer
Airborne Biomarkers for Colorectal Cancer
JTC 2016
View project
ANGELA
Early detection of esophageal squamous cell carcinoma with the Cytosponge coupled with molecular biomarkers and machine learning
JTC 2022
View project
BileCanMet
Precision medicine in cholangiocarcinoma: accurate tools for early detection and identification of PRMT5 as a novel pharmacological target
JTC 2022
View project
BioEndoCar
Biomarkers for diagnosis and prognosis of endometrial carcinoma
JTC 2016
View project
CLEARLY
Validation of multiparametric models and Circulating and imaging biomarkers to improve Lung cancer EARLY detection.
JTC 2016
View project
CTC-SCAN
Circulating Tumor Cells as Biomarker for Minimal Residual Disease in Prostate Cancer
JTC 2011
View project
DietINT
A randomized phase II study for tertiary prevention of squamocellular cancer of head and neck (SCCHN) with a dietary intervention
JTC 2013
View project
FAMILIAL CANCER
Cancer prevention through improved familial risk assessment and gene discovery
JTC 2012
View project
GRAN-T-MTC
Phase I clinical trial using a novel CCK-2/gastrin receptor-localizing radiolabelled peptide probe for personalized diagnosis and therapy of patiens with progressive or metastatic medullary thyroid carcinoma
JTC 2011
View project
HIGHCARE
High resolution project on prognosis and CARE of cancer patients
JTC 2013
View project
ImmuMet
Invigorating immunity against brain metastases in lung and breast cancer patients
JTC 2021
View project
IntraMMclo
Multiple myeloma intra-clonal heterogeneity: evolution and implications of targeted therapy
JTC 2014
View project
MELANOLOCK
Tackling resistance to immunotherapy in advanced melanomas through the inhibition of oncomiRs by Locked Nucleic Acids
JTC 2024
View project
MesaCapp
Mesalamine for Colorectal Cancer Prevention Program in Lynch syndrome
JTC 2012
View project
Microther
Improving immunotherapy of solid tumors by targeting the immunosuppressive tumor microenvironment: from pre-clinical "proof-of-concept" to the development of phase I studies
JTC 2015
View project
PREDICT
Personalized prevention of colorectal neoplasia by use of genetic variability for the prediction of efficacy and toxicity of treatment with COX-2 inhibitors and aspirin
JTC 2012
View project
PROLIPSY
Early Detection of Prostate Cancer by Liquid Biopsies
JTC 2016
View project
T-Plex EAC
T-Plex-Capture: Isolation of neoantigen-specific CD8+ T cell receptors for patient-specific immunotherapy in esophageal adenocarcinoma (EAC)
JTC 2022
View project
TENACITY
TargEting the Nectin fAmily to boost Cancer ImmuniTY
JTC 2021
View project
TOSCANINI
TAD disruption and aberrant expression as leukemia metabolic vulnerabilities for novel combination therapy tests in a drug screening platform
JTC 2024
View project
TRANsIBCCS
Development of a Comprehensive Risk Prediction Model for BRCA1 and BRCA2 mutation carriers
JTC 2012
View project